Vera Therapeutics (VERA) Non-cash Items (2021 - 2026)

Vera Therapeutics (VERA) has 6 years of Non-cash Items data on file, last reported at $169.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 5372.19% year-over-year to $169.5 million; the trailing twelve-month figure through Mar 2026 stood at $169.5 million (up 5372.19% YoY), and the FY2025 full-year result was $4.2 million, down 97.57% from the prior year.
• Non-cash Items for Q1 2026 stood at $169.5 million, down from $260.7 million in the prior quarter.
• Across five years, Non-cash Items topped out at $260.7 million in Q4 2025 and bottomed at $672992.0 in Q1 2022.
• The 5-year median for Non-cash Items is $2.4 million (2024), against an average of $37.2 million.
• Peak annual rise in Non-cash Items reached 6509.88% in 2024, while the deepest fall reached 19.75% in 2024.
• A 5-year view of Non-cash Items shows it stood at $1.2 million in 2022, then jumped by 126.91% to $2.6 million in 2023, then surged by 6509.88% to $172.6 million in 2024, then soared by 51.01% to $260.7 million in 2025, then tumbled by 34.99% to $169.5 million in 2026.
• The last three Non-cash Items figures came in at $169.5 million (Q1 2026), $260.7 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.

Peer Comparison